Noninvasive Method for Monitoring Pneumocystis carinii Pneumonia

Emerging Infectious Diseases

Volumn 9, Issue 12, 2003, Pages 1613-1616

  Linke, Michael J ^a   Rebholz, Sandy ^b   Collins, Margaret ^b   Tanaka, Reiko ^b   Cushion, Melanie T ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DNA; METHYLPREDNISOLONE ACETATE;

ANIMAL MODEL; CORTICOSTEROID THERAPY; IMMUNE DEFICIENCY; LUNG INFECTION; MALE; NONHUMAN; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS PNEUMONIA; PNEUMONIA; POLYMERASE CHAIN REACTION; RAT; REVIEW;

EID: 0344306548     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0912.030270     Document Type: Review

References (13)

1. Jones JL, Hanson DL, Dworkin, MS, Alderton DL, Fleming PL, Kaplan, JE, et al. Surveillance for AIDS-defining opportunistic illnesses 1992-1997. MMWR CDC Surveill Summ 1999;48:1-22.
2. Fisk DT, Meshnick S, Kazanjian PH. Pneumocystis carinii pneumonia in patients in the developing world who have acquired immunodeficiency syndrome. Clin Infect Dis 2003;36:70-8.
3. Icenhour CR, Rebholz SL, Collins MS, Cushion MT. Widespread occurrence of Pneumocystis carinii in commercial rat colonies detected using targeted PCR and oral swabs. J Clin Microbiol 2001;39:3437-41.
4. Icenhour CR, Rebholz SL, Collins MS, Cushion MT. Early acquisition of Pneumocystis carinii in neonatal rats as evidenced by PCR and oral swabs. Eukaryot Cell 2002;1:414-9.
5. Cushion MT, Ruffolo JJ, Linke MJ, Walzer PD. Pneumocystis carinii: growth variables and estimates in the A549 and WI-38 VA 13 human cell lines. Exp Parasitol 1985;60:43-54.
6. Palmer RJ, Cushion MT, Wakefield AE. Discrimination of rat-derived Pneumocystis carinii f. sp. carinii and Pneumocystis carinii f. sp. ratti using the polymerase chain reaction. Mol Cell Probes 1999;13:147-55.
7. Stahlberg A, Aman P, Ridell B, Mostad P, Kubista M. Quantitative real-time PCR method for detection of β-lymphocyte monoclonality by comparison of kappa and lambda immunoglobulin light chain expression. Clin Chem 2003;49:51-9.
8. Zheng M, Shellito JE, Marrero L, Zhong Q, Julian S, Ye P, et al. CD4+ T cell-independent vaccination against Pneumocystis carinii in mice. J Clin Invest 2001;108:1469-74.
9. Larsen HH, Kovacs JA, Stock F, Vestereng VH, Lundgren B, Fischer SH, et al. Development of a rapid real-time PCR assay for quantitation of Pneumocystis carinii f. sp. carinii. J Clin Microbiol 2002;40:2989-93.
10. Helweg-Larsen J, Jensen JS, Benfield T, Svendsen UG, Lundgren JD, Lundgren B. Diagnostic use of PCR for detection of Pneumocystis carinii in oral wash samples. J Clin Microbiol 1998;36:2068-72.
11. Helweg-Larsen J, Jensen JS, Lundgren B. Non-invasive diagnosis of Pneumocystis carinii pneumonia by PCR on oral washes. Lancet 1997;350:1363.
12. Palladino S, Kay I, Fonte R, Flexman J. Use of real-time PCR and the LightCycler system for the rapid detection of Pneumocystis carinii in respiratory specimens. Diagn Microbiol Infect Dis 2001;39:233-6.
13. Helweg-Larsen J, Masur H, Kovacs JA, Gill VJ, Silcott VA, Kogulan P, et al. Development and evaluation of a quantitative, touch-down, real-time PCR assay for diagnosing Pneumocystis carinii pneumonia. J Clin Microbiol 2002;40:490-4.